Navigation Links
Pfizer Oncology To Present New Clinical Data Across Ten Tumor Types and Multiple Molecular Targets
Date:10/7/2010

rug applications or supplemental drug applications that have been or may be filed for any such oncology product candidates or any such additional indications for in-line oncology products as well as their decisions regarding labeling and other matters that could affect their availability or commercial potential; and competitive developments.

A further description of risks and uncertainties can be found in Pfizer's Annual Report on Form 10-K for the fiscal year ended December 31, 2009 and in its reports on Form 10-Q and Form 8-K.

(1)  ESMO Accepted Abstract #365PD. Randomized phase 2 study of PF299804, an irreversible human epidermal growth factor receptor (EGFR) inhibitor, versus (v) erlotinib (E) in patients (pts) with advanced non-small cell lung cancer (NSCLC) after chemotherapy (CT) failure: quantitative and qualitative benefits. Poster Discussion. Sunday, October 10: 12:30 pm. Suresh Ramalingam – Presenter. 35th Congress of the European Society for Medical Oncology. Milan, Italy. October 8 - 12, 2010.  

(2)  ESMO Accepted Abstract # LBA18. Efficacy and safety of PF299804 as first-line treatment (tx) of patients (pts) with advanced non-small cell lung cancer (NSCLC) selected for activating mutation (mu) of epidermal growth factor receptor (EGFR). Proffered Paper (Oral Presentation). Monday, October 11: 14:00. Tony Mok - Presenter. 35th Congress of the European Society for Medical Oncology. Milan, Italy. October 8 - 12, 2010.  

(3)  ClinicalTrials.gov. PF-00299804 in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Standard Therapy for Advanced or Metastatic Cancer. Available at: http://clinicaltrials.gov/ct2/show/NCT01000025.  Accessed April 29, 2010.

(4)  ESMO Accepted Abstract # 366PD. Clinical Activity of Crizotinib (PF-02341066), in ALK-Positive Patients with
'/>"/>

SOURCE Pfizer Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
2. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
3. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
4. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
5. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
6. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
7. MannKind Addresses Pfizers Announcement Regarding Exubera
8. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
9. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
10. Medarex Receives Milestone Payment from Pfizer for Investigational New Drug Application Filing
11. Pfizer Contributes Critical Data to URMC Drug Safety Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... 2015 Zimmer Holdings, Inc. (NYSE and SIX: ... Advanced Bearing Technology with Vitamin E by celebrating a ... this month reported that, at 96 million cycles of ... Technology featuring Vitamin E grafted highly crosslinked polyethylene hip ... reduction of 95 percent, with no cracking, delamination or ...
(Date:3/26/2015)... -- Even the Score today marked this week,s 17 ... landmark approval of Viagra with the release of a ... the Agency to begin restoring gender equity in sexual ... most common sexual dysfunction. Currently, men have ... dysfunction – while women have zero biological treatment options ...
(Date:3/26/2015)... , March 26, 2015 ... and Drug Safety Software Market by Functionality (Adverse Event ... based (SAAS)), End-user (Pharma & Biotech Companies, CROs, ... MarketsandMarkets, the Pharmacovigilance and Drug Safety Software Market ... 6.5% during 2014-2019, and is expected to reach ...
Breaking Medicine Technology:Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 2Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 3Even The Score Marks 17th Viagra Anniversary with Release of New Letter from Members of Congress to FDA Calling for Equity in Sexual Health 2Even The Score Marks 17th Viagra Anniversary with Release of New Letter from Members of Congress to FDA Calling for Equity in Sexual Health 3Even The Score Marks 17th Viagra Anniversary with Release of New Letter from Members of Congress to FDA Calling for Equity in Sexual Health 4Pharmacovigilance and Drug Safety Software Market Worth $154.1 Million by 2019 2Pharmacovigilance and Drug Safety Software Market Worth $154.1 Million by 2019 3Pharmacovigilance and Drug Safety Software Market Worth $154.1 Million by 2019 4
... July 27, 2011 Reportlinker.com announces that ... in its catalogue: India ... Till 2016 http://www.reportlinker.com/p0575381/India-Cardiac-Catheters-and-Guidewires---Market-Trends-Till-2016.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Surgical_Equipment ... This market report provides vital ...
... 26, 2011 Symmetry Medical Inc. (NYSE: SMA ... orthopaedic device industry and other medical markets, announced today that ... period ending July 2, 2011 before the market opens on ... conference call at 8:00 a.m. ET on Thursday, August 4, ...
Cached Medicine Technology:India Cardiac Catheters and Guidewires - Market Trends Till 2016 2India Cardiac Catheters and Guidewires - Market Trends Till 2016 3Symmetry Medical to Report Second Quarter 2011 Financial Results on August 4, 2011 2
(Date:3/27/2015)... 2015 In light of two lawsuits ... U.S. District Court, District of Massachusetts; and case number ... of Pennsylvania), the San Diego personal injury lawyers of ... announcing that they are available to investigate potential ... were prescribed Zofran while pregnant and who gave birth ...
(Date:3/26/2015)... 26, 2015 Let’s not lose focus ... produce are today’s traffic magnets. Three out of 4 ... of their produce department, according to a Packaged Facts ... people are looking to add more fruits and vegetables ... Manager® Day is April 2. As featured in the ...
(Date:3/26/2015)... 2015 UC Davis will establish a ... origins of schizophrenia: A Silvio O. Conte Center for ... such centers in the United States. , The center ... the National Institutes of Mental Health, which will allow ... that an origin of schizophrenia may be dysregulation of ...
(Date:3/26/2015)... 26, 2015 Xarelto lawsuits ( ... with the issuance of new court documents in ... According to an Order dated March 24th, the ... Xarelto injury claims in the U.S. District Court, ... to file cases directly in the proceeding. (In ...
(Date:3/26/2015)... “The SWEET Act is an important step to invigorate the ... parents who are working to reduce sugar in their family ... public health, and we will continue to stand on the ... families,” said Dr. Jane Delgado President and CEO of the ... Sugar-Sweetened Beverage Tax (SWEET) Act by Congresswoman Rosa L. DeLauro. ...
Breaking Medicine News(10 mins):Health News:The Law Office of Melinda J. Helbock, A.P.C. Announces That It Is Now Accepting Case Reviews for Potential Zofran Birth Defect Lawsuits 2Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 2Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 3Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 4Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 2Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 3Health News:National Alliance for Hispanic Health Statement on Introduction of SWEET Act in 114th Congress 2
... the illness and depression, anxiety disorders, researchers say , ... of people with Parkinson,s disease are at increased risk ... The risk is particularly high in the brothers, sisters, ... age 75, said a team from the Mayo Clinic ...
... of Native American tribes, public health and environmental ... in,the U.S. Court of Appeals for the District ... that evade legally required cuts in,mercury pollution from ... broad coalition called for the complete reversal of ...
... Los,Angeles Jewish Home today broke ground on the first ... a decade, the newest in,California and the fastest-selling CCRC ... years after the city,s first senior housing was created ... to the number of,elderly residing in the region. Fountainview ...
... MOINES, Iowa, Dec. 6 A group of physicians ... appealing to both Democratic and,Republican candidates for President to ... highest quality hospitals, including their own., The appeal ... that was,prompted by threatened action by Senator Max Baucus, ...
... of Frutels, the Vitamin ... Gummy for Acne, ... principal of new business development consultancy BANKS., has,agreed to join Frutels, LLC ... years of executive marketing experience in apparel,cosmetics, fragrance and fashion accessories to ...
... to enhance care for Philadelphia Latinos, PHILADELPHIA, Dec. ... providing a total of $925,000 in funding through 2010,to ... of its,Charitable Medical Care Grant Program. The Grant program, ... that provide,free or low-cost health care to more than ...
Cached Medicine News:Health News:Relatives of Parkinson's Patients at Higher Psychiatric Risk 2Health News:EPA Plan to Evade Required Cuts in Mercury Pollution Challenged in Court by States, Tribes, Health and Environmental Groups 2Health News:Construction Begins on Los Angeles' First New Continuing Care Retirement Community Facility in Over a Decade 2Health News:Iowa-S. Dakota Physicians Appeal to Presidential Candidates: 'Help Defend America's Safest and Highest Quality Hospitals' 2Health News:Iowa-S. Dakota Physicians Appeal to Presidential Candidates: 'Help Defend America's Safest and Highest Quality Hospitals' 3Health News:Iowa-S. Dakota Physicians Appeal to Presidential Candidates: 'Help Defend America's Safest and Highest Quality Hospitals' 4Health News:Marketing Powerhouse Wendy Banks Joins Frutels' Advisory Board 2Health News:Independence Blue Cross Gives Grants to Support Health Care for the Uninsured 2
Pefakit PiCT UFH Controls...
Pefakit PiCT LMWH Controls...
Pefakit PiCT LMWH Calibrators...
Pefakit TAFI Calibrators and Controls...
Medicine Products: